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Purpose: Increased local production of matrix metalloproteinases (MMPs) is a potential 
mechanism underlying structural protein degradation in abdominal aortic aneurysms 
(AAA). With an elastase-induced rodent model of AAA, we determined whether 
pharmacologic treatment with an MMP-inhibiting tetracycline might limit the develop- 
ment of experimental AAA in vivo. 
Methods: Forty-eight Wistar rats underwent a 2-hour perfusion of the abdominal aorta 
with 50 U porcine pancreatic elastase and were then treated with either subcutaneous 
doxycycline (25 mg/day; n = 24) or saline solution vehicle (n = 24). Aortic diameter was 
measured before and after elastase perfusion was performed and before the rats were killed 
at 0, 2, 7, or 14 days, and AAAs were defined as an increase in aortic diameter to at least 
twice that before perfusion. At death the aortic tissues were either perfusion-fixed for 
histologic evaluation or extracted for substrate zymographic evaluation. 
Results: Aortic diameter was not different between groups at 0 or 2 days, but it was 
significantly less in animals treated with doxycycline at both 7 and 14 days (mean -+ SEM, 
p < 0.01). After day 2 the incidence of AAA was reduced from 83% (10 of 12 rats treated 
with saline solution) to 8% (1 of 12 animals treated with doxycycline). By histologic 
assessment doxycycline prevented the structural deterioration of aortic elastin without 
decreasing the influx of inflammatory cells. Increased aortic wall production of 92 kD 
gelatinase observed in a saline solution-treated control group was markedly suppressed in
animals treated with doxycycline. 
Conclusions: Treatment with an MMP-inhibiting tetracycline inhibits the development of
experimental AAA in vivo. This inhibition may be due to selective blockade of elastolytic 
MMP expression i  infiltrating inflammatory cells. Additional experiments, however, are 
necessitated to fully delineate this process. (J VAsc SURG 1996;23:336-46.) 
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Abdominal aortic aneurysms (AAAs are charac- 
terized by transmural aortic wall degeneration lead- 
ing to dilatation, progressive growth, and eventual 
rupture.l3 The most conspicuous histologic findings 
unique to AAA are destruction of the medial elastic 
lamellae, 46 chronic inflammation within the outer 
aortic wall, 7'8 and medial neovascularization. 9 In- 
creased local production of connective tissue protein- 
ases including serine elastases, l° plasminogen activa- 
tors, 11,i2 and matrix metalloproteinases (/VLViPs) 13"24 
has been well documented in human AAA tissues. 
Whereas any of  these enzymes might contribute to 
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aneurysmal degeneration bysustained degradation f
structurally important extracellular matrix proteins, 
recent studies suggest that MMPs, a family of 
zinc-dependent enzymes with a broad spectrum of 
connective tissue substrates, 2 '26 may play a particu- 
larly important role in the progressive pathobiologic 
condition of AAA. Indeed, our recent finding of 
increased local expression of 92 kD gclatinase by 
aneurysm-infiltrating macrophages supports the hy- 
pothesis that elastolytic metalloproteinases associated 
with chronic inflammation are involved in at least 
some stages of human aortic aneurysm disease. 2~ 
Experimental models of aortic aneurysm provide 
additional evidence that inflammatory cells and their 
proteolytic products are capable of causing aneu- 
rysmal degeneration. Perfusion of the rat aorta with 
porcine pancreatic elastase, a serine protease, results 
in aneurysmal dilatation, which begins at least 2 
days after perfusion and progresses over the next 2 
weeks. 27-3° A delayed onset of  aneurysmal expan- 
sion, or latency period, 29 consistently occurs in spite 
of the connective tissue injury produced by elastase 
perfusion, suggesting that other factors or events 
may be responsible for the subsequent degenerative 
response. Aneurysms also develop in rat aortas 
perfused with thioglycolate and plasmin to induce 
an inflammatory reaction without direct elastin 
degradation. 28 Thus structural protein degradation, 
aneurysm development, and progressive aortic di- 
latation are all temporally associated with the de- 
velopment of an aortic wall inflammatory esponse. 
Because these events are also correlated with an 
increase in endogenous MMP production, 29~3° the 
production of MMPs by various resident and 
infiltrating aortic wall cell types appears to be a 
potential mechanism underlying aneurysmal de- 
generation in this model and in human AAA 
disease. If this finding is true, pharmacologic n- 
hibition of metalloenzymes might provide a means 
by which to limit aortic aneurysm development and 
growth. 
Tetracycline antibiotics have attracted increasing 
interest as inhibitors of metalloproteinases, acting by 
molecular mechanisms distinct from their antimicro- 
bial properties. 3~36 Tetracyclines inhibit collagenase 
and other MMPs in vitro, and they effectively prevent 
MMP-mediated tissue injury in animal models of 
gingivitis, 31,32 arthritis, 33,34 and other disorders. 3sIn 
this study we report hat rats treated with doxycycline 
have decreased amage to the elastic media and 
limited aneurysmal dilatation after elastase perfusion 
of the aorta in spite of the induction of an inflam- 
matory response. The suppression of aortic wall 92 
kD gelatinase in animals treated with doxycycline 
indicates that at least one mechanism underlying this 
effect is inhibited production of metalloproteinases 
within the elastase-injured aorta. These findings 
strongly suggest hat elastolytic MMPs make an 
essential contribution to experimental ortic aneu- 
rysm development, and they demonstrate he feasi- 
bility of using tetracycllnes orother MMP inhibitors 
to limit the aneurysmal degeneration i itiated by 
elastolytic injury in vivo. 
METHODS 
Elastase-perfusion model of AAA. Male Wistar 
rats weighing 350 to 400 gm were cared for in 
accordance with a protocol approved by the Wash- 
ington University School of Medicine Animal Stud- 
ies Committee. All animals underwent elastase per- 
fusion of the aorta to induce aneurysmal degenera- 
tion as described by Anidjar et 01. 27,28 and others. 29,30 
In brief, rats were anesthetized with 6% pentobar- 
bital (0.1 ml/100 gm body weight), and operation 
was performed under sterile conditions with the 
assistance of a binocular surgical microscope (Leica, 
Deerfield, Ill.). Through a laparotomy incision the 
infrarenal abdominal aorta was dissected free of the 
inferior vena cava. The inferior mesenteric artery and 
all lumbar branches of the aorta below the left renal 
vein were ligated. A PE-10 polyethylene catheter 
(Baxter, McGraw Park, Ill.) was inserted into the 
femoral artery and advanced until its tip was located 
in the distal abdominal aorta. An atraumatic clamp 
was placed on the aorta at the level of the left renal 
vein, and a ligature was secured around the distal 
aorta to encompass the catheter just above the level of 
the aortic bifurcation. Over a 2-hour period the 1 cm 
segment of isolated aorta was perfused with 2 ml 
saline solution containing 25 U/ml type I porcine 
pancreatic elastase (E-1250, Sigma, St. Louis, Mo.) 
at i00 mm Hg pressure with a syringe pump (Sage 
Instruments, Boston, Mass.). The catheter was re- 
moved, the femoral artery was ligatcd, and the clamp 
was removed from the aorta to restore flow. The 
diameter of the aorta (AD) was measured insitu with 
a micrometer under physiologic conditions both 
before and after elastase perfusion was performed. 
The wounds were closed, and the animals were 
maintained in individual cages. After 0, 2, 7, or 14 
days animals underwent relaparotomy, at which time 
the aorta was exposed and the final aortic diameter 
measured. Two animals in each experimental group 
underwent systemic perfusion-fixation with 10% 
neutral buffered formalin for 15 minutes at 100 mm 
Hg, followed by removal of the aorta for histologic 
338 Petrinec et al. JOURNAL OF VASCULAR SURGERY 
February 1996 
¥ 
Pre Day 0 Day 2 Day 7 Day 14 
Fig. 1. Comparison of rat aortic diameter after elastase perfusion and treatment with either 
doxycycline or saline solution. Data shown are mean _+ SEM of aortic diameter for animals in 
each group (n = 6). Open circles, doxycycline-treated rats;closed squares, saline solution-treated 
control group. Abdominal aortic aneurysm, defined as increasein aortic diameter to at least twice 
that of preperfusion control, is indicated by dashed line. ~Significant difference between 
doxycycline- and saline solution-treated groups (p < 0.01, Student's t test). 
studies. In the rest of the rats the aorta was removed 
for biochemical studies and frozen at -70°C. 
Drug treatment. After aortic perfusion was 
performed, animals were treated with twice-daily 
subcutaneous injections of either Dox (12.5 mg in 
0.5 ml saline solution; Sigma) or saline solution 
vehicle (0.5 ml). Treatment was continued until the 
rats were killed. 
Histologic evaluation. Perfusion-fixed aortic 
specimens were immersed in 10% neutral buffered 
formalin overnight at 4°C and were then dehydrated 
through graded ethanols and embedded in paraf- 
fin. Specimens were cut in cross-section at 5 ~tm 
and attached to glass slides. Sections were stained 
with hematoxylin-eosin and Verhoeff-van Geisen for 
elastin. 
Aortic tissue extracts. Frozen aortic tissues 
(each approximately 50 rag) were pulverized in a 
mortar chilled with liquid nitrogen and extracted 
in 50 mmol/L Tris-HC1, pH 7.5, 1 mol/L NaC1, 
2 mol/L urea, 0.1% ethylenediamine tetraacetate, 
and 0.1% (wt/vol) Brij-35 for 20 minutes at 4°C. 
After centrifugation was performed at 10,000g for 1 
hour at 4°C, the supernatant was dialyzed overnight 
against 50 mmol/L Tris-HCl, pH 8.0, 1 mol/L NaCI, 
20 mmol/L CaCI 2 at 4°C with a 12,000 to 14,000 
molecular weight cutoff membrane. The total protein 
concentration f each sample was determined with a 
Bio-Rad protein assay with bovine serum albumin as 
the standard (Bio-Rad, Hercules, Calif.), and samples 
were stored at -20°C. 
Substrate zymography. Aortic extract samples 
were normalized to total protein, mixed with non- 
reducing sodium dodecylsulfate (SDS) sample 
buffer, and resolved by electrophoresis through 10% 
polyacrylamide g ls co-polymerized with 1 mg/ml 
gelatin or casein substrates (Sigma) as previously 
described.2~ After being incubated overnight at 37 ° C 
in substrate buffer (50 mmol/L Tris-HCl, pH 8.5, 5 
mmol/L CaC12, 0.2% NAN3) , gels were stained with 
0.1% Coomassie Blue R-250 in 40% methanol/10% 
acetic acid, and proteinases were observed as clear 
bands against adark background of intact substrate. 
The relative molecular weight of each band was 
estimated by comparison with the positions of 
known molecular weight standards (Bio-Rad) and a 
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Table I. Rat aortic diameter, increase in aortic diameter, and abdominal aortic aneurysms at 
various intervals after elastase perfusion 
Day AD (ram) AAD (mm) Percent A AAA* Percent AAA 
Rats treated with saline 
solution (n = 24) 
Pre 1.57 _+ 0.04 . . . .  
0 2.06 -+ 0.02 0.49 _+ 0.02 31% 0/6 0 
2 2.14 +- 0.05 0.57 +_ 0.02 36% 0/6 0 
7 3.54 _+ 0.27 1.97 + 0.02 125% 5/6 83 
14 4.26 _+ 0.64 2,69 +- 0.02 171% 6/6 100 
Rats treated with doxy- 
cycline (n = 24) 
Pre 1.56 -+ 0 .09  . . . .  
0 2.06 _+ 0.07 0.50 _+ 0.02 32 0/6 0 
2 2.14 + 0.07 0.58 + 0.02 37 0/6 0 
7 2.55 -+ 0.05t 0.99 -+ 0.02~ 63 0/65 0 
14 2.73 _+ O.18t 1.17 -+ 0.02~ 75 1/6~ 16 
AD, Aortic diameter; AAA, abdominal ortic aneurysm. 
*Number of individual nimals with abdominal ortic aneurysm, defined as AD r _ twofold (100%) greater than ADpr e. 
tp < 0.01, doxycycline v rsus aline solution, unpaired Student's t test. 
~p < 0.05, doxycycline v rsus aline solution, Yates corrected ×2 test. 
mixture of authentic human 92 kD and 72 kD 
gelatinases (gift of Dr. Howard G. Welgus, Wash- 
ington University, St. Louis, Mo.). The relative 
density of each lytic band was determined from 
negative photographic mages of gels with a GS 300 
scanning densitometer (Hoefer Scientific Instru- 
ments, San Francisco, Calif.). In experiments to 
determine the direct inhibitory effects of doxycycline 
on aortic extract gelatinolytic activities in vitro, 
samples were supplemented with varying concentra- 
tions of doxycydine before electrophoresis was per- 
formed, or the substrate buffer was supplemented 
with doxycycline during gel incubation. 
Data analysis. Measurements of preperfusion 
(ADwe), postperfusion (ADvost), and final aortic 
diameter (ADF: AD2, AD7, or AD14 ) for each group 
were compared by mean + SEM and an unpaired 
Student's t test. ax For each animal the increase in AD 
(AAD F = AD r - ADw~ ) was calculated with each 
animal as its own control, and comparisons between 
groups were based on the mean _+ SEM and Stu- 
dent's t test. The development of AAA for each 
animal was defined as a AAD F of at least 100% over 
the preperfusion control AD, and the incidence of  
AAA determined for each group was compared by 
the Yates corrected X 2 test. a7 For substrate zymogra- 
phy the relative density of gelatinolytic bands was 
exprcsscd in arbitrary units and compared between 
samples run on the same gel. 
RESULTS 
Prevention o f  the development and growth of  
elastase-induced abdominal aortic aneurysms by 
doxycycline. As shown in Table I all animals had 
mild aortic dilatation immediately after elastase 
perfusion, such that ADvost was increased by 30% to 
36% over ADpr e (mean AADp .... 33%). For animals 
that were treated with saline solution and killed at 2 
days, AD 2 was not significantly different from that 
measured after perfusion (mean AAD2, 34%). How- 
ever, by 7 days a substantial increase in AD was 
observed (mean AID7, 125%), and at this interval 
five (83%) of six animals had AAA. Animals treated 
with saline solution also had progressive aortic 
dilatation between 7 and 14 days, up to a maximum 
AAD14 of 187%, and all animals killed at this interval 
had AAA. 
Animals treated with doxycycline had signifi- 
cantly less aortic dilatation than their counterparts 
treated with saline solution at all time intervals after 
the second day (Table I, Fig. 1). Whereas animals 
treated with saline solution had a mean AAD 7 of 
125 %, the mean dlAD 7 was only 63% in those treated 
with doxycycline. At the 14-day interval similar 
results were obtained. Indeed, of 24 animals killed at 
7 or 14 days, 10 (83%) of 12 animals treated with 
saline solution had AAA, but only one aneurysm was 
observed in the 12 (8%) animals treated with 
doxycycline. Thus treatment with doxycycline uni- 
formly limited elastase-induced aortic dilatation and 
effectively prevented the development and continued 
growth of experimental ortic aneurysms. 
Prevention of  the progressive destruction o f  
aortic elastin induced by elastase perfusion by 
doxycycline without altering the inf lammatory 
response. Histologic sections of  rat aorta stained 
with Verhoeff-van Geisen were used to evaluate the 
structural integrity of the medial elastic lamellae in 
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Fig. 2. Histologic appearance of rat aorta at various intervals after elastase perfusion and 
treatment with saline solution or doxycycline. Elastase perfusion causes little detectable damage 
to elastic lamellae (arrows) up to 2 days (B). In saline solution-treated control group with 
aneurysmal dilatation, pronounced elastin degradation occurs by day 7 (C), associated with 
dense inflammatory response, whichis resolved by day I4 (E). In contrast, elastic lamellae are 
preserved innonaneurysmal doxycycline-treated rats both at 7 days (D) and 14 days (F), in spite 
of occurrence of inflammatory response similar to that seen in control group. At 14 days, outer 
aortic wall of doxycycline-treated rats is thicker, with more collagenous fibrosis, than that seen 
in saline solution-treated control group. (Verhoff-van Giesen stain, original magnification 
x 100.) 
each group of animals. As shown in Fig. 2, under the 
conditions used in this study little detectable damage 
to medial elastin was observed immediately after 
elastase perfusion was performed or 2 days later. By 
7 days all animals treated with saline solution had 
marked disruption, fragmentation, or therwise 
frank degradation of the elastic lamellae. In each 
animal amellar breakdown was particularly evident 
in areas associated with a dense inflammatory infil- 
trate, which typically extended through all layers of 
the aortic wall and was not present at 2 days (Figs. 2 
and 3). Progressive destruction of the elastic media 
was observed 14 days after elastase was performed, 
such that no remaining elastic structures were detect- 
able. At this time the aortic inflammatory esponse 
was largely resolved, and the wall appeared as a thin 
fibrous layer. Thus in animals that were treated with 
saline solution and underwent elastase perfusion, the 
morphologic hanges in aortic elastin were tempo- 
rally and spatially associated with aortic inflamma- 
tion, and the inflammatory esponse coincided with 
the development and growth of aortic aneurysms. 
In marked contrast to the rats treated with saline 
solution the elastic lamellae were uniformly intact in 
all animals treated with doxycycline. As shown in 
Figs. 2 and 3, doxycycline treatment effectively 
prevented the fragmentation and destruction of 
elastin that was observed in the control group at the 
7- and 14-day intervals. Like in the control group 
treated with saline solution, minimal inflammatory 
cells were observed at 2 days, and pronounced 
transmural inflammation was present at 7 days in the 
animals treated with doxycycline. However, even in 
areas where inflammatory cells were immediately 
adjacent o the elastic lamellae, little evidence of 
elastin degradation was seen (Fig. 3, C and D). The 
inflammatory esponse was completely absent by 14 
days, and the remaining aortic wall was composed of 
an intact elastic media and a fibrous adventitial layer 
of greater thickness than that seen in the control 
group treated with saline solution. Thus doxycycline 
had no observable effect on the development or 
resolution of aortic wall inflammation elicited by 
elastase perfusion, but it appeared to result in the 
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Fig. 3. Cellular infikration of rat aortic media 7 days after elastase-peffusion and treatment 
with saline solution (A and B) or doxycycline (C and D). Destruction of elastic lamellae is seen 
adjacent to infiltrating inflammatory cells in saline solution-treated control group, whereas 
elastic lamellae adjacent to i flammatory cells are preserved in animals treated with doxycycline. 
A and C, Verhoff-van Giesen stain, B and D, hematoxylin-eosin stain. (Original magnification 
x 200.) 
prevention of elastin degradation associated with the 
inflammatory cell response and the promotion of 
fibrous aortic wall healing. 
Aortic wall production of  92 kD gelatinase 
inhibited by doxycycline. Because the 92 kD and 72 
kD gelatinases are elastolytic metalloproteinases pro- 
duced in increased amounts during the course of 
experimental neurysm development, 29's° the effect 
ofdoxycycline treatment on aortic wall production of 
these enzymes was examined. Whereas aortic extracts 
from animals that were treated with saline solution 
and killed at 0 and 2 days contained little 92 kD 
gelatinase as detected by substrate zymography, large 
amounts of this enzyme were present in extracts from 
the 7-day group (Fig. 4). The 92 kD gelatinase was 
detected in both its full-length ~pro-form and its 80 
kD activated form, which was not seen at earlier 
times. In addition, the amount of 72 kD gelatinase 
present in 7-day extracts was increased over that from 
earlier intervals, along with the appearance of its 
lower molecular weight (N 62 kD) activated form. 
Although the amount of 92 kD gelatinase declined in 
14-day aortic extracts, the increased production of 72 
kD gelatinase and its activated forms persisted at this 
interval. 
Casein zymography was used to assess whether 
additional proteinases might be present in the tissue 
extracts. As shown in Fig. 4, 13, the principal 
caseinolytic band in aortic extracts migrated at -80  
to 92 kD, similar to that observed with gelatin 
zymography. In addition, a faint band was occasion- 
ally observed at approximately 30kD in extracts from 
animals that were treated with saline solution and 
killed on day 2, but this band was not apparent at later 
intervals. Whereas casein zymography effectively 
reveals porcine pancreatic elastase, which was used as 
a control during the assay, this enzyme was not 
detectable in aortic tissue extracts at any time point 
after aortic perfusion. 
Aortic wall extracts from animals treated with 
doxycycline and killed on day 7 contained levels of 92 
kD gelatinase that were essentially the same as those 
seen in control or in day-2 extracts, but these levels 
were significantly less than those present in day-7 
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Fig. 4. Comparison f enzymatic activities after elastase 
perfusion and treatment with saline solution (Sal) or 
doxycycline (Dox). Protein-normalized aortic extracts from 
unperfused rats (Pre) and elastase-perfused ratskilled at 2, 
7, or 14 days were examined by substrate zymography with 
gelatin (A) or casein (B) substrates. Control group 
included A, mixture of authentic human 92 and 72 kD 
gelatinases (92/72), and B, porcine pancreatic elas ase 
(PPE). 
extracts from animals treated with saline solution 
(Fig. 4,A, lanes 5 and 6; Fig. 5). On the other hand, 
the increased production of 72 kD gelatinase and its 
activated forms was apparently unaffected by doxy- 
cycline treatment (Figs. 4 and 5). Thus it appeared 
that the aneurysm-preventing effects of doxycycline 
might be closely related to its apparent inhibition of 
92 kD gelatinase production. 
Effects of doxycycline on 92 kD gelatinase in 
vitro. To further distinguish possible mechanisms 
underlying the effects of doxycycline on the devel- 
opment of elastase-induced rat aneurysms, the effect 
ofdoxycycline on aortic 92 kD gelatinase activity was 
examined in vitro. With gelatin zymography of 
extracts from animals treated with saline solution and 
killed on day 7, which contained elevated amounts of 
92 kD gelatinase, xogenous doxycycline was either 
mixed with the extract before electrophoresis was 
performed or was added to the substrate buffer 
before gel incubation was performed. As shown in 
Fig. 6,A, the addition of up to 1 mmol/L doxycycline 
before zymography was performed had no significant 
inhibitory effect on 92 kD gelatinase activity. Because 
any direct noncovalent interaction between the en- 
zyme and oxycycline might have been interrupted 
during sample preparation in SDS buffer or by 
electrophoresis, gels were also incubated in substrate 
buffers containing varying concentrations of doxycy- 
cline. Although mild direct inhibitory effects on 92 
kD and 72 kD gelatinase activities were observed, this 
result required oxycycline concentrations as high as 
20 ~m (Fig. 6, B). This inhibition was reversed by 
further supplementing the substrate buffer with 
ZnC12 (not shown), suggesting that at least one effect 
of doxycycline relates to direct interference with 
metal ions that are essential for metalloproteinase 
activity. Nevertheless the results of these latter 
experiments donot fully explain the inhibitory effects 
of doxycycline on 92 kD gelatinase production 
observed in vivo, and it remains likely that doxycy- 
cline acts predominantly o decrease cellular produc- 
tion of 92 kD gelatinase within the elastase-injured 
aortic wall . . . .  
DISCUSSION 
Elastase-induced injury of the rat aorta causes 
progressive aneurysmal degeneration associated with 
an aortic wall inflammatory esponse and the degra- 
dation of structural aortic wall proteins, thereby 
serving as a useful animal model of A_AA. 27-30 Like 
human aortic aneurysms the increased local produc- 
tion of MMPs has been suggested to be a potentially 
important mechanism ediating experimental aneu- 
rysm development. 29~3° In this study we used an 
MMP-inhibiting tetracycline derivative to further 
elucidate the role of MMPs in the development of
AAA in the elastase-induced ratmodel. Treatment 
with doxycycline was found to inhibit progressive 
aortic dilatation and to significantly imit the devel- 
opment of AAA up to 14 days after elastase 
per fusion. In addition, doxycycline prevented the 
destruction of medial elastin without altering the 
development of an aortic wall inflammatory re- 
sponse, and it suppressed the increased production of 
92 kD gelatinase that was otherwise observed within 
7 days of elastase-induced injury. Taken together, 
these results indicate that locally increased produc- 
tion of 92 kD gelatinase, an elastolytic MMP, is likely 
to be an essential step in the development of 
elastase-induced experimental ortic aneurysms. 
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Fig. 5. Relative density of 92 kD gelatinase (A) and 72 kD gelatinase (B) activities extracted 
from saline solution- and doxycycline-treated rat aortas at various intervals after elastase 
perfusion. For each gelatin-degrading band quantitated by densitometry of representative 
zymogram, relative density is expressed aspercent of day-0 control. 
MMPs represent a family of structurally related 
connective tissue nzymes that include interstitial col- 
lagenase (MMP- 1), 72 kD gelatinase/type IV collage- 
nase (MMP-2), stromelysin-1 (MMP-3), matrilysin 
(MMP-8), 92 kD gelatinase/type IV collagenase 
(MMP-9), macrophage metalloelastase (HME, 
MMP-12), and other proteinases. 2 '26 Although each 
family member is designated in part by its substrate 
specificity, considerable overlap of susceptible sub- 
strates occurs between various MMPs. As members 
of a locally acting proteolytic ascade, therefore, 
MMPs are capable of degrading virtually all of the 
structural, stromal, and basement membrane pro- 
teins within the aortic wall. At least four MMPs have 
recognized elastolytic activity, including the gelati- 
nases, matrilysin, and HME. ss4° Because AAAs are 
characterized bypronounced destruction of the me- 
dial elastic lamellae, these enzymes have been postu- 
lated to be of particular importance in the pathobio- 
logic condition of aneurysm disease. 
One of the significant observations made in this 
study was that doxycycfine had little effect on 
inflammatory cell infiltration of the aortic wall, yet it 
suppressed the increased production of 92 kD 
gelatinase. We and others have shown that 92 kD 
gelatinase is produced in increased amounts by 
human aneurysm tissues and that MMP-9 is localized 
to aneurysm-infiltrating macrophages. 13-z4 In the 
elastase-induced ratmodel of AAA, increased pro- 
duction of 92 kD gelatinase also occurs within 7 days 
of elastase perfusion coincident with the develop- 
ment of an inflammatory esponse. 29,3° This finding 
suggests that doxycycline either had a direct inhibi- 
tory effect on 92 kD gelatinase or on cellular enzyme 
production rather than on the inflammatory response 
itself. Although the cell type(s) expressing 92 kD 
gelatinase inthe rat aorta were not determined in this 
study, it would appear likely that this enzyme is 
produced by infiltrating macrophages or other in- 
flammatory cells that are known to express 92 kD 
gelatinase in other systems. 21,41 The finding that 92 
kD gelatinase production declines by day 14, when 
the inflammatory response has resolved, is also 
consistent with this hypothesis. However, Bendeck et 
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Fig. 6. Effect of doxycycline on rat aortic gelatinase activities in vitro. A, Aortic extract from 
7-day saline solution-treated animal in control group was mixed with doxycycline and analyzed 
by gelatin zymography. No inhibition of gelatinase activities by doxycycline is observed at any 
concentration tested. B, Control aortic extract used in A wasresolved by electrophoresis through 
gel containing gelatin substrate, and each lane was incubated in separate substrate buffers 
supplemented with doxycycline. Mild inhibition of both 92 kD and 72 kD gelatinase activities 
is observed at exogenous doxycycline concentrations of 20 ~tm. 
al.42 and Okada et al.43 have demonstrated that 
vascular smooth-muscle c lls (SMCs) are also capable 
of 92 kD gelatinase xpression and that increased 
production of this MMP is associated with SMC 
migration into the intima during balloon catheter- 
induced arterial injury that results in intimal thick- 
ening. Whereas the migration of SMC through the 
internal elastic lamina necessarily requires degrada- 
tion of elastic matrixes, it appears that the lastolytic 
activity of 92 kD gelatinase might have variable roles 
in vascular wall pathobiologic condition. Indeed, the 
factors distinguishing the increased production of 
this MMP in these two models of arterial wall injury, 
producing results at different ends of a structural 
spectrum, will require further examination. 
We also observed a consistent increase in 72 kD 
gelatinase production within 7 days ofelastase perfu- 
sion. In contrast o 92 kD gelatinase, the 72 kD 
enzyme remained persistently elevated 14 days later. 
The 72 kD gelatinase is generally produced by fibro- 
blasts, SMCs, and other mesenchyme-derived c ll
types rather than by inflammatory cells. 25'26 Because 
an increasing fibrotic reaction is seen within the aortic 
wall after resolution of the inflammatory response 
after 7 days, we postulate that the persistent produc- 
tion of 72 kD gelatinase may be a product of activated 
fbroblasts, SMCs, or both within the injured aortic 
wall. Indeed, a similar increase in 72 kD gelatinase 
production was observed by Bendeck et al. 42 after 
balloon catheter injury of the rat carotid artery. Be- 
cause the production of 72 kD gelatinase appeared to 
be unaffected by doxycycline treatment, his enzyme 
may be less important in the process of aneurysmal 
degeneration than 92 kD gelatinase. Thus although 
both 92 kD and 72 kD metallogelatinases are 
elastolytic, 38-4° their relative ffect on degradation of 
the elastic matrix may be more related to the cell types 
producing them, the relative abundance of their natu- 
ral inhibitors, and most important, he tissue localiza- 
tion of their activity rather than solely their recog- 
nized ability to degrade lastin substrates invitro. 
Our study raises additional questions regarding 
the specifc mechanisms by which doxycycline inhib- 
its experimental neurysm development. As shown 
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here by in vitro experiments and previously by other 
investigators, 31 34 tetracyclines have direct inhibitory 
effects on MMP activity, perhaps acting through 
mechanisms affecting the active-site zinc essential for 
enzyme activity. A drug-related effect on the nonac- 
tive site calcium ion(s) of MMPs, inhibiting the 
enzyme by induced conformational changes, may 
also occur. However, in this study the addition of 
doxycycline to extracts containing 92 kD gelatinase 
activity had no significant effect on the zymography 
results, suggesting that the binding of drug to 
enzyme is probably interrupted by the electro- 
phoretic onditions used in this technique. In addi- 
tion, whereas doxycycline directly inhibited both 92 
kD and 72 kD gelatinases by approximately equal 
amounts in vitro, extracts from animals treated with 
doxycycline contained lower amounts of 92 kD 
gelatinase with persistently elevated 72 kD gelatinase 
activity. Taken together, these data suggest that the 
effect of doxycycline in vivo may be more complex 
than that of direct enzyme inhibition alone, and they 
indicate that the cellular production of 92 kD 
gelatinase may have been selectively reduced by 
doxycycline in vivo. In support of this possibility, 
recent studies indicate that doxycycline can down- 
regulate the expression of MMP messenger ribo- 
nucleic acid in cultured cells. 36 Additional studies 
with Northern analysis and in situ hybridization to 
assess 92 kD gelatinase messenger ribonucleic acid 
expression i the elastase-injured rataorta will help to 
resolve these questions. 
Like other tetracycline derivatives, doxycycline 
inhibits a number of MMPs including interstitial col- 
lagenase and strornelysin. 33Although only gelati- 
nases were measured inthis study, it remains possible 
that additional MMPs are inhibited by doxycycline 
and that these might be as important in the develop- 
ment of AAA as 92 kD gelatinase appears to be. For 
example, inhibition of other MMPs may hinder the 
extravasation f inflammatory cells through capillary 
basement membranes, or it may limit endothelial cell 
migration as one component of an angiogenic re- 
sponse associated with inflammation. Tetracyclines 
might also act to limit elastolytic tissue injury by 
inhibiting metalloproteinase-mediated degradation 
of natural inhibitors uch as ch-antitrypsin , permit- 
ting s erine elastases to be more effectively inhibited.33 
Thus although we were unable to detect significant 
amounts of other enzymes by gelatin- or casein- 
zymography, a number of plausible mechanisms re- 
main by which doxycycline might have resulted in the 
aneurysm-inhibiting effects observed in this study. 
These possibilities will require elucidation in more 
detail before any potential role for tetracyclines in the 
pharmacotherapy of small asymptomatic AAA can be 
proposed. 
AAA remains an increasingly significant clinical 
problem, for which the only currently effective 
treatment is prosthetic surgical repair of the aorta. 1,2 
Whereas the optimal treatment for small asymptom- 
atic AAAs is undefined, for this group of patients the 
development of alternative treatment strategies to 
limit or prevent aneurysm growth would be particu- 
larly welcome. To date, such options have been 
limited by poor understanding of the basic cause(s) of 
aneurysm disease and the factors responsible for 
aneurysm expansion and rupture. Increasing knowl- 
edge of the role of MMPs in these processes has 
suggested that these nzymes might serve as potential 
targets for pharmacotherapy, and our finding that 
doxycycline prevents the development of experimen- 
tal AAA in the elastase-perfused rat model supports 
the use of MMP-inhibiting agents towards this aim. 
Further studies are required to explore the potential 
of this novel pharmacologic approach to limiting the 
growth of human AAA. 
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